You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 11, 2025

Drug Price Trends for TRIPROLIDINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TRIPROLIDINE

Average Pharmacy Cost for TRIPROLIDINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TRIPROLIDINE 0.938 MG/ML DROPS 69367-0253-30 0.49625 ML 2025-01-22
TRIPROLIDINE 0.938 MG/ML DROPS 69367-0253-30 0.51353 ML 2024-12-18
TRIPROLIDINE 0.938 MG/ML DROPS 69367-0253-30 0.50495 ML 2024-11-20
TRIPROLIDINE 0.938 MG/ML DROPS 00536-1257-75 0.53070 ML 2024-10-23
TRIPROLIDINE 0.938 MG/ML DROPS 69367-0253-30 0.53070 ML 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Triprolidine

Introduction to Triprolidine

Triprolidine is an antihistamine commonly used to treat allergic reactions, particularly those involving the respiratory system. It is known for its potent H1 receptor antagonist properties, making it effective in alleviating symptoms such as sneezing, runny nose, and itchy eyes[5].

Market Size and Forecast

The global triprolidine market is expected to grow at a moderate pace over the forecast period. Here are some key points:

  • The market is projected to increase at a Compound Annual Growth Rate (CAGR) of 3 to 5 percent from its estimated valuation by 2031[1].
  • The market size is categorized based on application (hospital, drug store, online), product (oral solution, syrup, chewable tablets), and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa)[1].

Market Segmentation

By Application

The triprolidine market is segmented into three main application areas:

  • Hospital: This segment includes the use of triprolidine in hospital settings, where it is often prescribed for severe allergic reactions.
  • Drug Store: This segment involves the retail sale of triprolidine through pharmacies and drug stores.
  • Online: The online segment is growing due to the increasing trend of online shopping for pharmaceuticals[1].

By Product

The market is also segmented based on the form of the drug:

  • Oral Solution
  • Syrup
  • Chewable Tablets Each form caters to different patient needs and preferences[1].

By Geography

The global market is divided into several geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle-East and Africa Each region has its own market dynamics and growth prospects[1].

Key Drivers and Restraints

Drivers

  • The increasing prevalence of allergic reactions and respiratory issues drives the demand for triprolidine.
  • Growing awareness about available treatment options and the expansion of healthcare infrastructure, including hospitals and pharmacies, also contribute to market growth[4].

Restraints

  • High manufacturing costs and the complexity of the production process can limit market expansion.
  • The availability of alternative antihistamines and potential side effects associated with triprolidine use can also restrain market growth[4].

Price Trends and Projections

Current Pricing

The price of triprolidine can vary based on the form and dosage. For example, the price per unit of Aprodine Tablet, a formulation containing triprolidine, is around $0.04683 as of December 2024[2].

Price Projections

Given the moderate growth rate of the market, prices are expected to remain relatively stable, with minor adjustments due to inflation and production costs. The overall drug price inflation rate for pharmaceuticals is projected to be around 3.81% in 2025, which could influence the pricing of triprolidine[2].

Manufacturers and Suppliers

The triprolidine market includes several key players:

  • Glaxosmithkline
  • Eskayef Pharmaceuticals
  • Sawai Pharmaceutical
  • Pai
  • Watson Laboratories
  • Zoetis
  • Delta Pharma
  • Aspen Pharma
  • Macter
  • Johnson and Johnson
  • Markos
  • Teva
  • Pharmaniaga
  • Yu Sheng
  • Trima
  • Tropica Pharma
  • Julphar
  • Pharco Corporation
  • Barrett Hodgson
  • Hasco-Lek
  • Xep[1].

End-Use Sector Trends

The demand for triprolidine is driven by various end-use sectors, including:

  • Respiratory Health: Triprolidine is widely used to treat respiratory allergies and conditions.
  • Dermatology: It is also used in dermatological applications to alleviate skin-related allergic reactions.
  • General Healthcare: The drug is prescribed in general healthcare settings for a variety of allergic conditions[4].

Regulatory Landscape

The regulatory environment plays a crucial role in the triprolidine market. Government policies and regulations regarding the use, manufacturing, and distribution of pharmaceuticals can significantly impact market dynamics. Continuous monitoring of the regulatory climate is essential to identify potential changes that could influence the market[3].

Technological Advancements

Technological advancements can lower production costs and enhance the efficacy and safety of triprolidine. Improvements in manufacturing processes and the use of advanced technologies in drug development and distribution can contribute to market growth[3].

Key Takeaways

  • The triprolidine market is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031.
  • The market is segmented by application, product form, and geographical region.
  • Key drivers include increasing prevalence of allergic reactions and expanding healthcare infrastructure.
  • Restraints include high manufacturing costs and potential side effects.
  • Prices are expected to remain relatively stable with minor adjustments due to inflation and production costs.

FAQs

1. What is the primary use of triprolidine?

Triprolidine is primarily used as an antihistamine to treat allergic reactions, particularly those involving the respiratory system.

2. Which regions are expected to drive the growth of the triprolidine market?

North America, Europe, and Asia-Pacific are expected to be key regions driving the growth of the triprolidine market.

3. What are the main forms in which triprolidine is available?

Triprolidine is available in oral solution, syrup, and chewable tablet forms.

4. Who are the major manufacturers of triprolidine?

Major manufacturers include Glaxosmithkline, Eskayef Pharmaceuticals, Sawai Pharmaceutical, and others.

5. What are the potential restraints on the triprolidine market?

High manufacturing costs, complexity of the production process, and potential side effects are significant restraints on the market.

Cited Sources:

  1. Market Research Intellect - Global Triprolidine Market Size and Forecast[1]
  2. Drug Patent Watch - Pharmaceutical drug prices and trends for APRODINE TABLET[2]
  3. Future Market Insights - Triptorelin Market Size, Growth, Trends & Forecast 2033[3]
  4. Research and Markets - Triprolidine (CAS 486-12-4) Global Market Research Report 2024[4]
  5. R&D Systems - trans-Triprolidine hydrochloride[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.